Evoke Pharma, Inc. (EVOK)
11.00
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Evoke Pharma Shareholders Equity (Quarterly) : 3.362M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 3.362M |
| June 30, 2025 | 4.374M |
| March 31, 2025 | 5.841M |
| December 31, 2024 | 7.038M |
| September 30, 2024 | 4.387M |
| June 30, 2024 | 2.665M |
| March 31, 2024 | 3.497M |
| December 31, 2023 | -2.580M |
| September 30, 2023 | -0.8738M |
| June 30, 2023 | 0.5384M |
| March 31, 2023 | 2.126M |
| December 31, 2022 | 4.085M |
| September 30, 2022 | 5.533M |
| June 30, 2022 | 7.191M |
| March 31, 2022 | 1.934M |
| December 31, 2021 | 3.555M |
| September 30, 2021 | 4.773M |
| June 30, 2021 | 5.966M |
| March 31, 2021 | 7.811M |
| December 31, 2020 | -3.215M |
| September 30, 2020 | -1.923M |
| June 30, 2020 | -0.3737M |
| March 31, 2020 | 2.922M |
| December 31, 2019 | 4.380M |
| September 30, 2019 | 5.173M |
| Date | Value |
|---|---|
| June 30, 2019 | 6.346M |
| March 31, 2019 | 3.075M |
| December 31, 2018 | 4.025M |
| September 30, 2018 | 5.408M |
| June 30, 2018 | 5.360M |
| March 31, 2018 | 4.389M |
| December 31, 2017 | 2.166M |
| September 30, 2017 | 2.060M |
| June 30, 2017 | 6.77M |
| March 31, 2017 | 7.934M |
| December 31, 2016 | 3.788M |
| September 30, 2016 | 4.703M |
| June 30, 2016 | -1.527M |
| March 31, 2016 | 0.7572M |
| December 31, 2015 | 3.465M |
| September 30, 2015 | 5.308M |
| June 30, 2015 | 4.312M |
| March 31, 2015 | 6.433M |
| December 31, 2014 | 9.189M |
| September 30, 2014 | 11.69M |
| June 30, 2014 | 15.17M |
| March 31, 2014 | 18.45M |
| December 31, 2013 | 21.18M |
| September 30, 2013 | 19.22M |
| June 30, 2013 | -1.936M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.65M |
| Total Liabilities (Quarterly) | 12.29M |